Arcturus Therapeutics Holdings Inc. (ARCT) Cash Flow Statement
Arcturus Therapeutics Holdings Inc. (ARCT) generated -$72.7M of operating cash flow over the twelve months to 2026-06-30, spent $93000 on capital expenditure and had free cash flow of -$72.8M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ARCTArcturus Therapeutics Holdings Inc.Follow ARCT — free
—
Price chart with a free account
- Market cap
- 279.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -6.4 | -42.9 | -135.0 | 32.0 | -18.1 | -59.7 | -74.3 | -72.7 | |
| Capital expenditure | 0.8 | 1.7 | 3.4 | 7.7 | 2.9 | 0.6 | 0.2 | -0.1 | |
| Free cash flow | -7.3 | -44.6 | -138.4 | 24.3 | -21.0 | -60.4 | -74.5 | -72.8 | |
| Stock-based compensation | 2.0 | 6.8 | 28.9 | 30.6 | 34.6 | 38.0 | 25.4 | — |
USD millions · SEC XBRL
Arcturus Therapeutics Holdings Inc. — questions
- What is Arcturus Therapeutics Holdings Inc.'s operating cash flow?
- -$72.7M over the twelve months to 2026-06-30.
- How much does Arcturus Therapeutics Holdings Inc. spend on capital expenditure?
- $93000 over the twelve months to 2026-06-30.
- What is Arcturus Therapeutics Holdings Inc.'s free cash flow?
- -$72.8M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Arcturus Therapeutics Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.